Skip to main content

Table 5 Seroprevalence of anti-HEV IgM among population with chronic hepatitis B infection in Rushan county, Shandong province, China

From: Comparison of hepatitis E virus seroprevalence between HBsAg-positive population and healthy controls in Shandong province, China

 

Number detected

Positive number

Positive rate (%, 95% CI)

P value

Total

1022

16

1.57 (0.90–2.53)

–

Age group (yrs)

 Under 30

66

0

0 (0–5.44)

0.768

 30–39

79

1

1.26 (0.03–6.85)

 

 40–49

242

6

2.48 (0.92–5.32)

 

 50–59

336

5

1.49 (0.48–3.44)

 

 60–69

211

3

1.42 (0.29–4.10)

 

 Above 70

88

1

1.14 (0.03–6.17)

 

Gender

 Male

516

8

1.55 (0.67–3.03)

0.969

 Female

506

8

1.58 (0.68–3.09)

 

Clinical typea

 HBV carrier

838

12

1.43 (0.74–2.49)

0.060#

 Chronic cases

74

0

0 (0–4.86)

 

 Cirrhosis

8

0

0 (0–36.94)

 

 HCC

3

1

33.33 (0.84–90.57)

 
  1. HBV hepatitis B virus, HCC hepatic cellular cancer
  2. # Fisher’s exact test
  3. aNinety nine participants with unknown clinical type were not involved in the analysis